Personal information

Japan

Activities

Funding (13)

低分子量Gタンパク質シグナル系が血管の構築・維持を制御する新たな分子機構

がん細胞と間質細胞との相互作用ががんの浸潤・転移を制御する新たな分子機構

Source: Self-asserted source
Hisakazu Ogita via DimensionsWizard

A New Diagnostics Method for Refractory Heart Failure

2012-04-01 to 2015-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: grant.24591097
Source: Self-asserted source
Hisakazu Ogita via DimensionsWizard

がん細胞と周囲環境の相互作用における接着分子ネクチンと関連分子の役割と作用機構

Pleiotropic effects of afadin, an scaffold molecule, on regulation of cellular functions

Source: Self-asserted source
Hisakazu Ogita via DimensionsWizard

Roles of Cell Adhesion and Signaling in Cell Morphogenesis

2009-04-01 to 2015-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: grant.21227005
Source: Self-asserted source
Hisakazu Ogita via DimensionsWizard

Roles of the nectin-afadin system in epithelial-mesenchymal and mesenchymal-epithelial transitions

Source: Self-asserted source
Hisakazu Ogita via DimensionsWizard

細胞の極性形成における低分子量Gタンパク質の役割と作用機構

Source: Self-asserted source
Hisakazu Ogita via DimensionsWizard

Physical and functional interaction among nectin, integrin, and platelet-derived growth factor

Source: Self-asserted source
Hisakazu Ogita via DimensionsWizard

細胞間接着における低分子量Gタンパク質の役割と作用機構

Source: Self-asserted source
Hisakazu Ogita via DimensionsWizard

Role of cell adhesion signaling in the abnormal cell polarization of cancer cells

Source: Self-asserted source
Hisakazu Ogita via DimensionsWizard

新規接着分子ネクチンとインテグリンとの協調作用による細胞間接着の形成機構

Source: Self-asserted source
Hisakazu Ogita via DimensionsWizard

細胞増殖のシグナリング機構

2000-01-01 to 2004-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: grant.12215079
Source: Self-asserted source
Hisakazu Ogita via DimensionsWizard

Peer review (20 reviews for 4 publications/grants)

Review activity for Biochemical pharmacology. (15)
Review activity for Communications biology. (1)
Review activity for Journal of Molecular and Cellular Cardiology. (3)
Review activity for Metabolism, clinical and experimental. (1)